Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Workhorse Group
WKHS
$34.9M
| $2.07M | ﹤0.01% |
+40
| New | +$434K |
|
2077
Morningstar
MORN
$7.66B
| $2.07M | ﹤0.01% |
14,650
+14,250
| +3,563% | +$2.01M |
|
2078
Pediatrix Medical
MD
$2.13B
| $2.06M | ﹤0.01% |
120,693
+66,460
| +123% | +$985K |
|
2079
Aaon
AAON
$7.1B
| $2.06M | ﹤0.01% |
56,993
+6,396
| +13% | +$215K |
|
2080
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.1B
| $2.06M | ﹤0.01% |
72,579
+8,480
| +13% | +$232K |
|
2081
PUT
Clorox
CLX
$13B
| $2.06M | ﹤0.01% |
9,400
-41,500
| -82% | -$8.29M |
|
2082
Independent Bank
INDB
$3.95B
| $2.06M | ﹤0.01% |
30,705
+3,092
| +11% | +$208K |
|
2083
Insight Enterprises
NSIT
$4.47B
| $2.06M | ﹤0.01% |
41,776
+5,472
| +15% | +$269K |
|
2084
Pacira BioSciences
PCRX
$971M
| $2.06M | ﹤0.01% |
39,185
-441
| -1% | -$18.4K |
|
2085
Chewy
CHWY
$9.36B
| $2.05M | ﹤0.01% |
45,966
-825
| -2% | -$36K |
|
2086
Cavco Industries
CVCO
$4.49B
| $2.05M | ﹤0.01% |
10,649
+498
| +5% | +$81.6K |
|
2087
Energizer
ENR
$1.49B
| $2.05M | ﹤0.01% |
43,187
-17
| -0% | -$695 |
|
2088
PUT
Mondelez International
MDLZ
$78.6B
| $2.04M | ﹤0.01% |
40,000
-49,500
| -55% | -$2.54M |
|
|
SMAR
2089
DELISTED
Smartsheet Inc.
SMAR
| $2.04M | ﹤0.01% |
40,123
-57,888
| -59% | -$2.95M |
|
2090
CALL
TotalEnergies
TTE
$194B
| $2.04M | ﹤0.01% |
53,100
-251,600
| -83% | -$9.32M |
|
2091
PUT
RH
RH
$3.6B
| $2.04M | ﹤0.01% |
8,200
-35,000
| -81% | -$6.34M |
|
2092
CALL
Target
TGT
$69B
| $2.04M | ﹤0.01% |
17,000
-155,400
| -90% | -$17.7M |
|
|
CVET
2093
DELISTED
Covetrus, Inc. Common Stock
CVET
| $2.04M | ﹤0.01% |
113,973
-88,569
| -44% | -$1.16M |
|
|
CMBT
2094
CMB.TECH NV
CMBT
$4.7B
| $2.04M | ﹤0.01% |
250,040
-2,088,298
| -89% | -$20.8M |
|
2095
PUT
Stryker
SYK
$131B
| $2.04M | ﹤0.01% |
11,300
-17,700
| -61% | -$3.27M |
|
|
ROIC
2096
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $2.03M | ﹤0.01% |
179,466
+8,765
| +5% | +$85K |
|
2097
Hamilton Lane
HLNE
$5.5B
| $2.03M | ﹤0.01% |
30,157
+20,796
| +222% | +$1.31M |
|
2098
Diodes
DIOD
$4.72B
| $2.03M | ﹤0.01% |
40,050
+4,871
| +14% | +$233K |
|
|
RETA
2099
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.03M | ﹤0.01% |
13,000
| – | – |
|
|
AAN.A
2100
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $2.03M | ﹤0.01% |
44,636
+4,864
| +12% | +$221K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.